Figure 2From: Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatmentEffect of AL-1 on serum insulin level in diabetic mice. Alloxan-induced diabetic mice were treated with AL-1, Andro or glibenclamide by intragastric administration once daily for 6 days. On day 6, serum insulin levels were detected. Each column represents the mean ± S.D. of 6 mice. *P < 0.05 vs. normal group, **P < 0.01 vs. diabetic group. Gli: glibenclamide.Back to article page